Share this post on:

Product Name :
Trimebutine Maleate

Search keywords :
Trimebutine

drugId :
null

Target Vo:
Opioid receptors

Target Vo Short Name :
Opioid receptors

Moa_Name:
Opioid receptors agonists

First Approval Country :
Japan

First Approval Date Filter:
1984

Origin Company_Name :
Mitsubishi Tanabe Pharma

Active Company_Name :
Kaikai Yuansheng Pharmaceutical Co Ltd

Active Indication_Name:
Irritable Bowel Syndrome

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD133 Mouse mAb Purity & Documentation
LC3B Rabbit pAb MedChemExpress
Phospho-Tau (Thr181) Antibody: Phospho-Tau (Thr181) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Thr181). It can be used for WB,IP assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related